D000726Chemicals & DrugsPhysiologyD06.347.065D27.505.696.399.450.0651324090.794905Androgen AntagonistsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonGenitourinary Medical OncologyRadiation OncologyMD AndersonCHRISTOPHER JLOGOTHETISCHRISTOPHER J LOGOTHETIS8480LOGOTHETIS, CHRISTOPHER JProfessorELENIEFSTATHIOUELENI EFSTATHIOU9209EFSTATHIOU, ELENIAssociate ProfessorKARENHOFFMANKAREN HOFFMAN9633HOFFMAN, KARENAssociate ProfessorDEBORAH AKUBANDEBORAH A KUBAN8889KUBAN, DEBORAH AProfessor74Professor21Chair14Associate Professor5.425950.00188717132research area of0.9723040.00949634265subject area forBaylor College of MedicineDANIELHAMSTRADANIEL HAMSTRA16519HAMSTRA, DANIELProfessortrue1ProfessorProfessor34784577De Giorgi U, Hussain M, Shore N, Fizazi K, Tombal B, Penson D, Saad F, Efstathiou E, Madziarska K, Steinberg J, Sugg J, Lin X, Shen Q, Sternberg CNEuropean journal of cancer (Oxford, England : 1990)Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region. Eur J Cancer. 2021 12; 159:237-246.Eur J Cancer2021-11-14T00:00:002021Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region.34940861Nowakowska MK, Lei X, Wehner MR, Corn PG, Giordano SH, Nead KTJAMA network openAssociation of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer. JAMA Netw Open. 2021 12 01; 4(12):e2140803.JAMA Netw Open2021-12-01T00:00:002021Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer.34978488Luckenbaugh AN, Wallis CJD, Huang LC, Wittmann D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Penson DF, Barocas DAThe Journal of urologyAssociation between Treatment for Localized Prostate Cancer and Mental Health Outcomes. J Urol. 2022 05; 207(5):1029-1037.J Urol2022-03-03T00:00:002022Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.35277153Leith A, Ribbands A, Kim J, Clayton E, Gillespie-Akar L, Yang L, Ghate SRBMC urologyImpact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan. BMC Urol. 2022 Mar 11; 22(1):33.BMC Urol2022-03-11T00:00:002022Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan.37707804Sherry AD, Corn PG, Tang CJAMA oncologyMetastases-Targeting Radiotherapy and ADT-Reply. JAMA Oncol. 2023 Nov 01; 9(11):1587-1588.JAMA Oncol2023-11-01T00:00:002023Metastases-Targeting Radiotherapy and ADT-Reply.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorDepartment of Radiation OncologyRadiation Oncology